UNSPSC 51282809: Nimorazole

This classification denotes an antiprotozoal agent with the molecular formula C9H14N4O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 469ULX0H4G, chemically known as morpholine, 4-(2-(5-nitroimidazol-1-yl)ethyl)- but generally known as nimorazole, which bears US NIH Compound Identifier 23009. European Medicines Agency schedules Nimorazole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09298MIG.

UNSPSC 51282809 Nimorazole is a Commodity code for a specific antiprotozoal pharmaceutical product, but recent state and local procurement activity under this code does not reflect direct solicitation for nimorazole itself. Instead, the tagged opportunities show state and local health agencies procuring related pharmaceutical products through piggyback and competitive bidding processes — specifically antibiotics (doxycycline, ciprofloxacin) and emergency medical supplies (naloxone, drug deactivation systems) — typically in multi-unit quantities for public health stockpiling, emergency preparedness, or community health programs. The issuing bodies are state health departments and county health and emergency management offices.

The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical warehouse contract through the MMCAP Infuse consortium to Chartwell Rx LLC in August 2026 for doxycycline hyclate and ciprofloxacin hydrochloride tablets over a three-year term, while Seminole County, Florida released an IFB in June 2026 for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and a two-year initial term plus one-year renewal option. Recent activity clusters in Florida and Illinois, with procurement through both piggyback cooperative purchasing vehicles and traditional competitive bidding. The mismatch between the code's nominal product (nimorazole) and the actual recent opportunities tagged under it suggests either metadata alignment issues or broader pharmaceutical procurement categorization — vendors evaluating this code should verify whether opportunities involve nimorazole specifically before investing pre-bid effort.